![]() To avoid hypoglycaemia, timely dose reduction or cessation of Glimepiride therapy must be considered. Secondary dosage adjustment: As control of diabetes improves, sensitivity to insuiin increases therefore, Glimepiride requirement may fall as treatment proceeds. It is very important not to skip meals after taking the drug. This should be taken immediately before a substantial breakfast or if none is taken immediately before the first main meal. Normally, a single daily dose is sufficient. Any increase can be based on regular blood sugar monitoring, and should be gradual, i.e., at intervals of 1 to 2 weeks, and carried out stepwise, as follows: 1 mg -> 2 mg -> 3 mg -> 4 mg -> 6 mg.ĭose in patients with well controlled diabetes: the usual dose range in patients with well controlled diabetes is 1 to 4 mg daily.ĭistribution of doses: Timing and distribution of doses are decided by the physician, in consideration of the patient's current life-style. Initial dose and dose titration: the usual initial dose is 1 mg once daily, if necessary, the daily dose can be increased. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. The dosage of Glimepiride must be the lowest which is sufficient to achieve the desired metabolic control. Lab administrator self-support leveraging existing LabVantage knowledge of functions, configuration tools, and other skills.In principle, the dosage of Glimepiride is governed by the desired blood sugar level.Simple and intuitive user experience with clean, cockpit-style screens that allow users to navigate safely, efficiently, and with little or no training.Customers’ choice of “apps” that deliver various functions, such as Portal account management, request submissions, status tracking and test-results viewing, and requests for test kits.A secure customer self-service web Portal for external clients of the lab, ensuring faster and more complete client-submitted requests and direct access to more meaningful information and data.This new Portal protects customers’ valuable and sensitive data, while eliminating the need for manual requests for tests and other services.Ī new, next-generation user interface makes Portal features easier than ever to use for those outside the lab needing access to data but who are not familiar with LIMS. The latest version of LabVantage LIMS includes a redesigned web portal that lets LabVantage customers extend appropriate access rights to their clients outside the laboratory. ![]() LabVantage 8.7 Introduces Secure Web Portal ![]() Accessibility – LabVantage Portal is certified for compliance with the Web Content Accessibility Guidelines (WCAG) international standard, Section 508, to provide increased accessibility to the platform.Cyber protection – Enhanced security against OWASP Top 10 threats, and includes third-party certification of testing. ![]() Automatic redo calculations automatically triggers re-calculation when a reference is modified to improve accuracy and data quality.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |